Relay Therapeutics Inc (RLAY)
6.82
-0.16
(-2.29%)
USD |
NASDAQ |
May 24, 16:00
6.82
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Shareholders Equity (Quarterly): 745.76M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 745.76M |
| December 31, 2023 | 752.00M |
| September 30, 2023 | 778.37M |
| June 30, 2023 | 810.12M |
| March 31, 2023 | 883.41M |
| December 31, 2022 | 950.22M |
| September 30, 2022 | 999.77M |
| June 30, 2022 | 779.64M |
| March 31, 2022 | 841.97M |
| Date | Value |
|---|---|
| December 31, 2021 | 897.81M |
| September 30, 2021 | 571.09M |
| June 30, 2021 | 618.53M |
| March 31, 2021 | 732.79M |
| December 31, 2020 | 763.29M |
| September 30, 2020 | 713.52M |
| June 30, 2020 | -225.39M |
| March 31, 2020 | 335.43M |
| December 31, 2019 | -180.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-225.39M
Minimum
Jun 2020
999.77M
Maximum
Sep 2022
653.77M
Average
757.65M
Median
Shareholders Equity (Quarterly) Benchmarks
| Olema Pharmaceuticals inc | 236.32M |
| Moderna Inc | 12.82B |
| Exelixis Inc | 2.128B |
| Geron Corp | 344.87M |
| Regeneron Pharmaceuticals Inc | 26.99B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 841.44M |
| Total Liabilities (Quarterly) | 95.68M |
| Current Ratio | 20.73 |